Sun-Woo Hong
Algemeen Directeur bij mCureX Therapeutics, Inc.
Vermogen: 706 890 $ op 30-04-2024
Profiel
Sun-Woo Hong is currently the Chief Executive Officer at mCureX Therapeutics, Inc. Prior to this, he worked as the Director, Senior Managing Director & Head-Research at OliX Pharmaceuticals, Inc. Dr. Hong completed his undergraduate and doctorate degrees from Pohang University of Science & Technology and his graduate degree from Korea University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 28-03-2024 | 62 348 ( 0.38% ) | 706 890 $ | 30-04-2024 |
Actieve functies van Sun-Woo Hong
| Bedrijven | Functie | Begin |
|---|---|---|
mCureX Therapeutics, Inc.
 mCureX Therapeutics, Inc. BiotechnologyHealth Technology mCureX Therapeutics, Inc. is a South Korean company that specializes in drug development. The private company is based in Seongnam-si, South Korea. The company is known for being the first mover in the mRNA drug development market. It was founded in 2021 and the CEO is Sun-Woo Hong. | Algemeen Directeur | 01-01-2021 |
Eerdere bekende functies van Sun-Woo Hong
| Bedrijven | Functie | Einde |
|---|---|---|
| OLIX PHARMACEUTICALS, INC | Directeur/Bestuurslid | - |
Opleiding van Sun-Woo Hong
| Pohang University of Science & Technology | Doctorate Degree |
| Korea University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| OLIX PHARMACEUTICALS, INC | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
mCureX Therapeutics, Inc.
mCureX Therapeutics, Inc. BiotechnologyHealth Technology mCureX Therapeutics, Inc. is a South Korean company that specializes in drug development. The private company is based in Seongnam-si, South Korea. The company is known for being the first mover in the mRNA drug development market. It was founded in 2021 and the CEO is Sun-Woo Hong. | Health Technology |
